Pfizer's pipeline prioritization has now turned to a STING agonist, with an early-stage study termination of the asset, a ...
Pfizer has terminated a Phase I trial of its investigational STING therapy in advanced solid tumors, according to an update ...
Although several STING agonists — cyclic dinucleotides (CDNs) and non-CDNs — are currently in clinical trials, these must be injected intratumourally or intravenously. Very few scaffolds of ...
The fatality is considered to be related to the drug treatment, according to the biotech, which is developing the STING agonist in collaboration with GSK under the terms of a $1.3 billion option ...
Hosted on MSN1y
Metalloimmunotherapy: Combination of cisplatin and STING agonist into one molecule boosts cancer immune responseMore information: Shuren Zhang et al, Combining cisplatin and a STING agonist into one molecule for metalloimmunotherapy of cancer, National Science Review (2024). DOI: 10.1093/nsr/nwae020 ...
STING/TLR-agonist Antibody-Drug Conjugates and mRNA technologies You will also have the opportunity to ask any burning questions and go back to your teams with a full picture of the innate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback